Literature DB >> 15637034

Inflammatory arthritis and dermatitis in thymectomized, CD25+ cell-depleted adult mice.

A Loughry1, S Fairchild, N Athanasou, J Edwards, F C Hall.   

Abstract

OBJECTIVE: To investigate the effect of CD25+ or CTLA-4(+) cell depletion on the natural history of collagen-induced and spontaneous arthritis in male DBA1/J mice.
METHODS: Male DBA/1J mice were treated with anti-CD25 depleting antibody (PC61) or isotype control (GL113), or with anti-CTLA-4 depleting antibody (4F10) at various time-points peri- and post-immunization with bovine collagen type II, emulsified in adjuvant. In order to develop a model system in which long-term depletion of CD25+ regulatory T cells can be achieved prior to immunization, adult male DBA/1J mice were thymectomized prior to administration of either PC61 or GL113. An ELISA demonstrated that PC61 and GL113 antibodies were undetectable by 21 days after administration and FACS analysis confirmed the long-term depletion of CD25+ cells in peripheral blood.
RESULTS: In the thymectomized mice treated with PC61, the CD25+ population was depleted and a spontaneous arthritis developed (P = 0.03). In the non-thymectomized mice, administration of CTLA-4-depleting antibody prior to immunization exacerbated arthritis in mice immunized with bovine collagen type II emulsified in incomplete Freund's adjuvant (P < 0.01). However, no significant difference in the natural history of arthritis was evident in mice treated with CD25-depleting antibody (PC61) compared with control antibody (GL113).
CONCLUSIONS: Two separate models implicate CD25+ CTLA-4(+) constitutive cells in suppression of arthritis in susceptible DBA/1 males: exacerbation of collagen-induced arthritis following CTLA-4 depletion at the start of induction and spontaneous arthritis in the thymectomy/CD25+ depletion model.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15637034     DOI: 10.1093/rheumatology/keh477

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  5 in total

1.  Genetic regulation of T regulatory, CD4, and CD8 cell numbers by the arthritis severity loci Cia5a, Cia5d, and the MHC/Cia1 in the rat.

Authors:  Max Brenner; Teresina Laragione; Nuriza C Yarlett; Pércio S Gulko
Journal:  Mol Med       Date:  2007 May-Jun       Impact factor: 6.354

2.  Anti-CD25 antibody treatment of mice vaccinated and challenged with Borrelia spp. does not exacerbate arthritis but inhibits borreliacidal antibody production.

Authors:  Dean T Nardelli; Thomas F Warner; Steven M Callister; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2006-08

3.  Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection.

Authors:  Khaled S Tabbara; Nathan C Peters; Farhat Afrin; Susana Mendez; Sylvie Bertholet; Yasmine Belkaid; David L Sacks
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria.

Authors:  Fiona H Amante; Amanda C Stanley; Louise M Randall; Yonghong Zhou; Ashraful Haque; Karli McSweeney; Andrew P Waters; Chris J Janse; Michael F Good; Geoff R Hill; Christian R Engwerda
Journal:  Am J Pathol       Date:  2007-06-28       Impact factor: 4.307

5.  Age-related changes in arthritis susceptibility and severity in a murine model of rheumatoid arthritis.

Authors:  Oktavia Tarjanyi; Ferenc Boldizsar; Peter Nemeth; Katalin Mikecz; Tibor T Glant
Journal:  Immun Ageing       Date:  2009-06-11       Impact factor: 6.400

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.